Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION) - NCT05465213

Dados básicos

Código:
Estudo Observacional Comercial (EVOLUTION)
Protocolo:
Estudo Observacional Comercial (EVOLUTION)
EUDRACT:
NCT:
NCT05465213
Centro:
Dotação:
Ano de início:
2023
Ano de conclusão:
2024
Estudos observacionais Internacional Finan. Não Competitivo Privada

Objectivos do projeto

Tipo de Estudo: Estudo Observacional – Iniciativa da Indústria; Subtipo: Coorte; Fase: Retrospectivo; Natureza do Promotor: Indústria Farmacêutica – Tipo comercial; Tipo de Centro: Multicêntrico – Cuidados Secundários – Centro de Ensaio: CHUSJ – Doença investigada: Insuficiência cardíaca – Participantes recrutados: 25;

Documentos

  • Não há documentos

Participantes

Unidades de investigação

Stakeholders - Promotores

AstraZeneca
AstraZeneca

Outputs do ensaio clínico


Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study

Valdiviesso, R.; (...); Borges, N.

Article. 10.1186/s12872-023-03632-x. 2023

  • Open Access.

Cardiovascular magnetic resonance in muscular dystrophies: looking ahead

Amador, AF; (...); Martins, E.

Article. 10.4081/monaldi.2024.2851. 2024


Cardiovascular magnetic resonance in muscular dystrophies: looking ahead.

Amador, AF; (...); Martins, E

Article. 2024


conTemporary reflectiOns regarding heart failure manaGEmenT ? How to ovERcome the PorTuguese barriers (TOGETHER-PT); [Reflex?es contempor?neas sobre a gest?o da insufici?ncia card?aca ? Como ultrapassar as barreiras em Portugal]

Silva Cardoso, J.; (...); Pimenta, J.

Article. 10.1016/j.repc.2023.05.012. 2023

  • Open Access.

Frailty phenotype in heart failure: A condition that transcends age

Valdiviesso, R; (...); Borges, N

Article. 10.1016/j.repc.2022.02.009. 2023

  • Open Access.

Global Variations in Heart Failure Etiology, Management, and Outcomes

Joseph, P; (...); Yusuf, S

Article. 10.1001/jama.2023.5942. 2023

  • Open Access.

Portuguese adaptation of the Chronic Heart Failure Knowledge Questionnaire (KQCHF)

Azzam, AP; (...); Castro, S

Article. 10.1186/s12872-023-03325-5. 2023

  • Open Access.

Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design - A population-based study

Baptista, R; (...); Gavina, C.

Article. 10.1016/j.repc.2023.10.004. 2023

  • Open Access.

Recommendations for the Management of Cardiomyopathy Mutation Carriers: Evidence, Doubts, and Intentions

Couto, JF, Martins, E.

Review. 10.3390/jcm12144706. 2023

  • Open Access.

Socioeconomic Inequalities and Predictors of Cardiac Rehabilitation Referral: Real-World Evidence

Rocha, JA; (...); Cardoso, JCS

Article. 10.1097/PHM.0000000000002270. 2023


The association between pre-existing heart failure and cancer incidence: A systematic review and meta-analysis

Barbosa, C; (...); Martins, E.

Article. 10.1016/j.repc.2023.10.015. 2024

  • Open Access.

The association between pre-existing heart failure and cancer incidence: A systematic review and meta-analysis.

Barbosa, C; (...); Martins, E

Review. 2024


Cardiac Findings Using Advanced Imaging According To Sports Activities: A Review

Trabalho final de curso

Colaboradores: Elisabete Lousada Martins Oliveira Bernardes


Diagnostic Accuracy Of Cardiovascular Magnetic Resonance Imaging In Cardiac Tumors: A Systematic Review With Meta-Analysis

Projeto de fim de curso

Colaboradores: Elisabete Lousada Martins Oliveira Bernardes


High-Sensitivity Cardiac Troponin I As A Reliable Prognosis Biomarker In Patients With Hypertrophic Cardiomyopathy

Projeto de fim de curso

Colaboradores: Elisabete Lousada Martins Oliveira Bernardes


Left Bundle Branch Block-Induced Cardiomyopathy: Definition(S), Pathophysiology, And Therapy

Trabalho final de curso

Colaboradores: Elisabete Lousada Martins Oliveira Bernardes


Pr Interval In Hypertrophic Cardiomyopathy Patients: An Easy And Worthy Risk Factor?

Projeto de fim de curso

Colaboradores: Elisabete Lousada Martins Oliveira Bernardes


Recommendations For The Management Of Cardiomyopathy Mutation Carriers: Evidence, Doubts And Intentions

Trabalho final de curso

Colaboradores: Elisabete Lousada Martins Oliveira Bernardes


Serositis In Patients With Systemic Lupus Erythematosus: Characteristics And Associates

Projeto de fim de curso

Colaboradores: Elisabete Lousada Martins Oliveira Bernardes


Telemedicine: An Effective Tool For Up-Titration Of Prognosis-Modifying Hfref Therapy

Projeto de fim de curso

Colaboradores: José Carlos de Magalhães Silva Cardoso


The Association Between Pre-Existing  Heart Failure And Cancer Incidence: A Systematic Review And Meta-Analysis

Projeto de fim de curso

Colaboradores: Elisabete Lousada Martins Oliveira Bernardes


Partilhar